MENICHELLI, DANILO
 Distribuzione geografica
Continente #
NA - Nord America 1.671
EU - Europa 848
AS - Asia 326
AF - Africa 38
SA - Sud America 6
OC - Oceania 3
Totale 2.892
Nazione #
US - Stati Uniti d'America 1.651
IT - Italia 463
SG - Singapore 159
SE - Svezia 83
IN - India 80
AT - Austria 55
CN - Cina 49
TG - Togo 30
FI - Finlandia 29
DE - Germania 28
GB - Regno Unito 28
ID - Indonesia 23
IE - Irlanda 23
RO - Romania 20
BG - Bulgaria 19
RU - Federazione Russa 17
CA - Canada 16
UA - Ucraina 14
FR - Francia 13
NL - Olanda 13
CH - Svizzera 8
GR - Grecia 8
ES - Italia 6
BE - Belgio 5
PH - Filippine 5
MX - Messico 4
PL - Polonia 4
AU - Australia 3
MK - Macedonia 3
ZA - Sudafrica 3
BR - Brasile 2
CL - Cile 2
DZ - Algeria 2
EE - Estonia 2
JP - Giappone 2
SI - Slovenia 2
TH - Thailandia 2
AM - Armenia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.892
Città #
Fairfield 280
Rome 140
Ashburn 137
Chandler 130
Seattle 118
Houston 117
Singapore 117
Wilmington 104
Woodbridge 95
Cambridge 81
San Paolo di Civitate 78
Princeton 51
Vienna 46
Ann Arbor 40
Lawrence 39
Millbury 38
San Diego 34
Lomé 30
Dearborn 24
Santa Clara 24
Dublin 23
Jakarta 23
Helsinki 22
New York 19
Sofia 19
Milan 18
Beijing 17
Fremont 17
Plano 14
Boston 13
Florence 13
Pescara 13
Andover 10
Toronto 10
London 9
Boardman 8
Hyderabad 7
Norwalk 7
St Petersburg 7
Athens 6
Los Angeles 6
Phoenix 6
Dallas 5
Salerno 5
Avellino 4
Bremen 4
Charlotte 4
Denver 4
Madrid 4
Mannheim 4
Moscow 4
Naples 4
Perugia 4
Pordenone 4
Saint Etienne 4
Alzate Brianza 3
Brussels 3
Bühl 3
Edinburgh 3
Frankfurt am Main 3
Hefei 3
Jacksonville 3
Lappeenranta 3
Manchester 3
Montreal 3
Paceco 3
Redwood City 3
Renens 3
Shanghai 3
Southend 3
Sulmona 3
Tanza 3
Trieste 3
Algiers 2
Alimos 2
Aubusson 2
Bacoli 2
Bangkok 2
Bari 2
Bolzano Vicentino 2
Bonndorf 2
Brescia 2
Cagliari 2
Cascina 2
Cervignano d'Adda 2
Chicago 2
Chieti 2
Chongqing 2
Des Moines 2
Dongguan 2
Durban 2
Galatina 2
Genazzano 2
Genoa 2
Ghent 2
Grosotto 2
Jinan 2
Kilburn 2
Legnaro 2
Lerma 2
Totale 2.172
Nome #
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation 128
Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients? 104
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort 103
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet 102
Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation 101
Features of severe COVID-19. a systematic review and meta-analysis 99
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients 93
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding 92
Statins and major adverse limb events in patients with peripheral artery disease. a systematic review and meta-analysis 90
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review 76
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study 76
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 76
Hazelnut and cocoa spread improves flow-mediated dilatation in smokers 71
Oxidative stress and cardiovascular disease: New insights 68
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach 68
Integrated care management of patients with atrial fibrillation and risk of cardiovascular events. the abc (atrial fibrillation better care) pathway in the ATHERO-AF study cohort 68
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation 65
Silybin and metabolic disorders 65
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department 61
How to treat patients with splanchnic vein thrombosis. recent advances 59
Update and unmet needs on the use of nonvitamin k oral anticoagulants for stroke prevention in patients with atrial fibrillation 58
Direct oral anticoagulants and advanced liver disease. a systematic review and meta-analysis 58
A comprehensive review of risk factors for venous thromboembolism. from epidemiology to pathophysiology 57
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes. insights from the multicenter START-ANTIPLATELET registry 56
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. a prospective multicenter cohort study 55
The atrial fibrillation better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. the ATHERO-AF study 54
Relation of atrial fibrillation to angiographic characteristics and coronary artery disease severity in patients undergoing percutaneous coronary intervention 54
Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves. insights from the nationwide plectrum study 54
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management 53
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis 52
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study 51
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation. a multicentre cohort study 49
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis 48
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study 47
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation. a network metanalysis on 605,771 patients 47
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment 45
Multiple arterial thrombosis in seronegative antiphospholipid syndrome. need for new diagnostic criteria 44
Family history of atrial fibrillation and risk of cardiovascular events. a multicenter prospective cohort study 43
Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis 37
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk 37
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 37
Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants 35
Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study 33
Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines 32
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes. from the START antiplatelet registry 31
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management. a case report 28
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer. a nationwide cohort study 28
Mediterranean diet: a tool to break the relationship of atrial fibrillation with the metabolic syndrome and non-alcoholic fatty liver disease 26
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry 26
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients 26
Bleeding and thrombotic events in atrial fibrillation patients with cancer. a systematic review and meta-analysis 23
Risk of venous thromboembolism in autoimmune diseases. A comprehensive review 20
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. insights from the nationwide PLECTRUM registry 20
Efficacy and safety of combination therapy with low-dose rivaroxaban in patients with cardiovascular disease. A systematic review and meta-analysis of randomized controlled trials 18
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation 17
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry 15
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease. A comprehensive systematic-review and meta-analysis 14
Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations 13
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients 10
Serum albumin, clotting activation and COVID-19 severity: a systematic review and meta-regression analysis of 4579 patients 10
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium? 9
Acute upper and lower gastrointestinal bleeding management in older people taking or not taking anticoagulants: a literature review 9
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation 8
Usefulness of the C2HEST score to predict new onset atrial fibrillation. A systematic review and meta‐analysis on >11 million subjects 7
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes 6
Prediction of new-onset atrial fibrillation with the C2HEST score in patients admitted with community-acquired pneumonia 6
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis 6
Long-term risk of hospitalization and death in patients with mechanical prosthetic heart valves 5
Statins under-treatment and mortality in patients with atrial fibrillation. insights from the nationwide START registry 5
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. insights from the nationwide START registry 4
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses 4
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation. the MAS study 4
Totale 3.199
Categoria #
all - tutte 12.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 37 53 55 39 40 47 34 15
2020/2021503 31 17 56 42 4 22 50 13 57 97 79 35
2021/2022578 20 20 47 22 69 39 12 48 36 35 113 117
2022/2023723 109 181 51 66 59 62 9 68 42 18 50 8
2023/2024474 14 55 24 37 45 57 13 50 28 49 53 49
2024/2025351 55 26 101 103 66 0 0 0 0 0 0 0
Totale 3.199